Efficacy of Radial Versus Femoral Access in the Acute Coronary Syndrome Is It the Operator or the Operation That Matters?

Sunil V. Rao; James Nolan; Douglas G. Fraser; Mamas A. Mamas; Olivier F. Bertrand; Samir B. Pancholy; Ivo Bernat; Surya Dharma; Sasko Kedev; Sanjit S. Jolly; Marco Valgimigli

doi:10.1016/j.jcin.2016.02.032

Efficacy of Radial Versus Femoral Access in the Acute Coronary Syndrome Is It the Operator or the Operation That Matters?

Sunil V. Rao
, James Nolan
, Douglas G. Fraser
, Mamas A. Mamas
, Olivier F. Bertrand
, Samir B. Pancholy
, Ivo Bernat
, Surya Dharma
, Sasko Kedev
, Sanjit S. Jolly
, Marco Valgimigli

Department of Cardiology and Vascular Medicine

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	978-979
Number of pages	2
Journal	JACC: Cardiovascular Interventions
Volume	9
Issue number	9
DOIs	https://doi.org/10.1016/j.jcin.2016.02.032
Publication status	Published - 9 May 2016

Access to Document

10.1016/j.jcin.2016.02.032

Cite this

Rao, S. V., Nolan, J., Fraser, D. G., Mamas, M. A., Bertrand, O. F., Pancholy, S. B., Bernat, I., Dharma, S., Kedev, S., Jolly, S. S., & Valgimigli, M. (2016). Efficacy of Radial Versus Femoral Access in the Acute Coronary Syndrome Is It the Operator or the Operation That Matters? JACC: Cardiovascular Interventions, 9(9), 978-979. https://doi.org/10.1016/j.jcin.2016.02.032

@article{18acf949dec74df3b903c17dee8e30aa,

title = "Efficacy of Radial Versus Femoral Access in the Acute Coronary Syndrome Is It the Operator or the Operation That Matters?",

author = "Rao, \{Sunil V.\} and James Nolan and Fraser, \{Douglas G.\} and Mamas, \{Mamas A.\} and Bertrand, \{Olivier F.\} and Pancholy, \{Samir B.\} and Ivo Bernat and Surya Dharma and Sasko Kedev and Jolly, \{Sanjit S.\} and Marco Valgimigli",

note = "Funding Information: Please note: This manuscript was prepared without external funding. Dr. Rao has received research grant support from Bellerophon and consulting honoraria from AstraZeneca, Medtronic, Terumo Interventional Systems, Merck, and CSI. Dr. Pancholy has served as a consultant for Terumo. Dr. Valgimigli has received research grant support from The Medicines Company and Terumo. All other authors have reported that the have no relationships relevant to the contents of this paper to disclose. ",

year = "2016",

month = may,

day = "9",

doi = "10.1016/j.jcin.2016.02.032",

language = "English",

volume = "9",

pages = "978--979",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",